Cellectar Biosciences (CLRB) Shares Outstanding (Entity) (2010 - 2026)
Cellectar Biosciences' Shares Outstanding (Entity) came in at 12.23 million for Q2 2026, up 575.0% from 1.81 million a year earlier.
Powered by 
Analysis
Cellectar Biosciences (CLRB) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends
For FY2025, Cellectar Biosciences' Shares Outstanding (Entity) was 2.61 million, up 113.7% from FY2024.
- Shares Outstanding (Entity) has increased in each of the last 15 years, with a five-year compound annual growth rate of 108.6% (FY2020 to FY2025).
- Going back by year, Shares Outstanding (Entity) was 1.22 million in FY2024 (+199.7%), 407,345 in FY2023 (+73.2%), 235,165 in FY2022 (+15.5%) and 203,651 in FY2021 (+208.4%).
- The Q2 2026 figure represents the highest quarterly Shares Outstanding (Entity) in data going back to Q2 2010.
- The year-over-year growth in Shares Outstanding (Entity) has ranged between 0.0% (Q3 2022) and 575.0% (Q2 2026) over the last five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 941.36 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 2.41 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 540.60 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Cellectar Biosciences | 15.41 Mn | -55.37 Mn | - | 12.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.23 Mn |
| Dec 31, 2025 | 2.61 Mn |
| Sep 30, 2025 | 3.19 Mn |
| Jun 30, 2025 | 1.81 Mn |
| Mar 31, 2025 | 1.54 Mn |
| Dec 31, 2024 | 1.22 Mn |
| Sep 30, 2024 | 1.35 Mn |
| Jun 30, 2024 | 1.19 Mn |
| Mar 31, 2024 | 1.11 Mn |
| Dec 31, 2023 | 407,345.00 |
| Sep 30, 2023 | 330,580.00 |
| Jun 30, 2023 | 324,651.00 |
| Mar 31, 2023 | 324,651.00 |
| Dec 31, 2022 | 235,165.00 |
| Sep 30, 2022 | 203,650.00 |
| Jun 30, 2022 | 203,650.00 |
| Mar 31, 2022 | 203,650.00 |
| Dec 31, 2021 | 203,651.00 |
| Sep 30, 2021 | 203,651.00 |
| Jun 30, 2021 | 184,208.00 |
API Access
Cellectar Biosciences Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=CLRB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "CLRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=CLRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();